1. Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar.
- Author
-
Warrell CE, Macrae C, McLean ARD, Wilkins E, Ashley EA, Smithuis F, and Tun NN
- Subjects
- AIDS-Related Opportunistic Infections epidemiology, AIDS-Related Opportunistic Infections virology, Administration, Intravenous, Administration, Oral, Adolescent, Adult, Amphotericin B adverse effects, Antifungal Agents adverse effects, Cryptococcus neoformans isolation & purification, Deoxycholic Acid adverse effects, Drug Combinations, Drug Therapy, Combination, Female, Fluconazole adverse effects, Humans, Male, Meningitis, Cryptococcal epidemiology, Meningitis, Cryptococcal microbiology, Middle Aged, Myanmar epidemiology, Phlebitis chemically induced, Retrospective Studies, Treatment Outcome, Young Adult, AIDS-Related Opportunistic Infections complications, Amphotericin B administration & dosage, Antifungal Agents administration & dosage, Cryptococcus neoformans immunology, Deoxycholic Acid administration & dosage, Fluconazole administration & dosage, HIV, Meningitis, Cryptococcal complications, Meningitis, Cryptococcal drug therapy, Primary Health Care
- Abstract
Background: Cryptococcal meningitis (CM) is a common HIV-associated opportunistic-infection worldwide. Existing literature focusses on hospital-based outcomes of induction treatment. This paper reviews outpatient management in integrated primary care clinics in Yangon., Method: This retrospective case note review analyses a Myanmar HIV-positive patient cohort managed using ambulatory induction-phase treatment with intravenous amphotericin-B-deoxycholate (0.7-1.0 mg/kg) and oral fluconazole (800 mg orally/day)., Results: Seventy-six patients were diagnosed between 2010 and 2017. The median age of patients diagnosed was 35 years, 63% were male and 33 (45%) were on concurrent treatment for tuberculosis. The median CD4 count was 60 at the time of diagnosis. Amphotericin-B-deoxycholate infusions precipitated 56 episodes of toxicity, namely hypokalaemia, nephrotoxicity, anaemia, febrile reactions, phlebitis, observed in 44 patients (58%). One-year survival (86%) was higher than existing hospital-based treatment studies., Conclusion: Ambulation of patients in this cohort saved 1029 hospital bed days and had better survival outcomes when compared to hospital-based studies in other resource constrained settings.
- Published
- 2021
- Full Text
- View/download PDF